Dividends & Buybacks ·
Curanex Pharmaceuticals Inc filed a Certificate of Amendment with the Nevada Secretary of State to implement a…
CURXCuranex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc filed a Certificate of Amendment with the Nevada Secretary of State to implement a 1-for-20 reverse stock split. The action became effective at 12:01 a.m. Pacific Time on August 20, 2026. This corporate action converts every 20 outstanding shares into one share, reducing the total issued and outstanding common stock from approximately 31,364,812 to roughly 1,568,241 shares. The company intends for its Common Stock to begin trading on a reverse split-adjusted basis under the symbol CURX on August 20, 2026. This move aims to regain compliance with Nasdaq's $1.00 minimum bid price requirement. Curanex Pharmaceuticals Inc operates in the biopharmaceutical industry, focusing on drug discovery and development.